Home → News items

We have two courses at DIS (DIS Study Abroad in Scandinavia) that are in need of a part time faculty.

  • For the immunology course we are looking for someone to co-teach it.
  • For the “Medical Biotechnology and Drug Development” we need someone to fully teach the course (in total around 16 classes during a semester, and potentially travel with students (3 days in Denmark and/or 1 week in Edinburgh))

You can find information about the Immunology course here: http://disabroad.org/copenhagen/courses/immunology/

and the Medical Biotechnology and Drug Development here: http://disabroad.org/copenhagen/summer-courses/medical-biotechnology-and-drug-development/

Anyone who might be interested can contact me.

Susana LS Dietrich, PhD

Assistant Program Director

Science & Health Department

Dir. +45 33 76 54 42

Mob: +45 30 67 10 42

sd@dis.dk

DIS · Study Abroad in Scandinavia

www.DISabroad.org

DIS Copenhagen

Vestergade 7 · DK 1456 Copenhagen K · Denmark

A three-year Senior post-doc position funded by a research grant from the Danish Council for Independent Research (DFF) to Lars Hviid is available in the SURFACE team at CMP (http://cmp.ku.dk/research/teamsurface/). The starting date for the position(s) is 1 July 2016 or as soon as possible thereafter

Find out more or look at the web side from the group

POSTDOCTORAL POSITION available June, 2016 to study molecular mechanisms controlling lymphoid development and transformation.

Find out more

Four postdoctoral positions are available immediately at Georgia Cancer Center’s Center for Immuno-Oncology in the field of basic and translational research in cancer immunology and Immunotherapy.
The positions available are in the following areas of investigations:

  1. CD8 Biology, CD4 Plasticity, and T cell Receptor Signaling
  2. Rational Combination Immunotherapy Design
  3. Inflammation and Immunology and Obesity & Cancer

For potential candidates, please contact: Dr. Samir N. Khleif at skhleif@gru.edu

Find out more

Please find attached an advertisement for the opening of a Group Leader Position in Immunology at the Centre d’Immunologie de Marseille-Luminy, Marseille, France (CIML, http://www.ciml.univ-mrs.fr/). Deadline for application is soon: June 20th 2016.

Find out more

One Postdoc position (Norwegian Cancer Society) is available for a period of three years, from June 2016. This is a shared position at the Section for Cancer Immunology/IKF (Smeland/Myklebust) and Section for Cellular Therapy /KKT (Kvalheim), Radiumhospitalet-OUS.

The Section for Cellular therapy is home to one of Europe’s biggest and most modern GMP facilities for cellular products and also provides cellular products for industry trials abroad. The section counts 35 employees and the research focus of the translational research team at the section is the development of new immunotherapy treatments for cancer. This includes the pre-clinical and clinical development and testing of improved cancer vaccines and adoptive T cell therapy.

Find out more

EDGE (Training network providing cutting-EDGE knowlEDGE on Herpes Virology and Immunology) is a Marie Skłodowska-Curie Innovative Training Network for early stage researchers (ESRs) funded by the European Commission under the H2020 Programme, the EU framework programme for research and innovation.

Deadline for applications: May 6, 2016

Find out more

The Pinschewer laboratory solicits applications by postdoctoral scientists and PhD students interested in the area of adaptive immunity to chronic viral infection.

Find out more

Position as postdoc and research coordinator at Klinisk Biokemisk Afdeling, Roskilde Sygehus, Copenhagen Universitetshospital, Region Sjælland.

A three year position as postdoc and coordinator of research projects at Klinisk Biokemisk Afdeling, Roskilde Sygehus, Købehavns Universitetshospital, Region Sjælland, is available for start at 01.05.2016 or soon after. Application deadline 21/3-2016.

Read more (only in Danish)

15 positions as Early Stage Researcher (PhD student) in the field of Immunotherapy of Cancer.

Description: IMMUTRAIN is a research network of nine academic research groups and five industrial partners in nine European countries. The joint goal is to train the next generation of scientists in the field of immunotherapy of cancer. The research objective of IMMUTRAIN is to enhance the efficacy of antibody-based tumor therapies through combination with other immunotherapeutic approaches. Please find further information at www.immutrain.eu

Application deadline is March 4th 2016

Find out more